Sunitinib Before and After Surgery in Treating Patients With Stage IV Kidney Cancer

NCT00717587 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Kidney Cancer

Interventions

DRUG: motexafin gadolinium
DRUG: sunitinib malate
GENETIC: comparative genomic hybridization
GENETIC: gene expression analysis
GENETIC: mutation analysis
GENETIC: polymorphism analysis
OTHER: immunohistochemistry staining method
OTHER: iodine I-124 girentuximab
OTHER: laboratory biomarker analysis
OTHER: pharmacological study
PROCEDURE: adjuvant therapy
PROCEDURE: neoadjuvant therapy
PROCEDURE: therapeutic conventional surgery

Sponsor

Abramson Cancer Center at Penn Medicine

Collaborators

[object Object]